back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2025-04-09 15:46 Tx date 2025-02-18 |
$APS
Aptose Biosciences Inc. |
Whitehead, Warren
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-34,509 vol |
1,187 | |
| Filed 2025-04-09 15:45 Tx date 2025-02-18 |
$APS
Aptose Biosciences Inc. |
Whitehead, Warren
4 - Director of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-966 vol |
33 | |
| Filed 2025-04-09 15:43 Tx date 2025-02-18 |
$APS
Aptose Biosciences Inc. |
Vincent, Mark
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-37,311 vol |
1,284 | |
| Filed 2025-04-09 15:42 Tx date 2025-02-18 |
$APS
Aptose Biosciences Inc. |
Vincent, Mark
4 - Director of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-419 vol |
14 | |
| Filed 2025-04-09 15:41 Tx date 2025-02-18 |
$APS
Aptose Biosciences Inc. |
Seizinger, Bernd Robert
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-12,888 vol |
444 | |
| Filed 2025-04-09 15:39 Tx date 2025-02-18 |
$APS
Aptose Biosciences Inc. |
Seizinger, Bernd Robert
4 - Director of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-16,434 vol |
566 | |
| Filed 2025-04-09 15:38 Tx date 2025-02-18 |
$APS
Aptose Biosciences Inc. |
Rice, William Glenn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
37 - Stock split or consolidation
|
-48,333 vol |
1,667 | |
| Filed 2025-04-09 15:37 Tx date 2025-02-18 |
$APS
Aptose Biosciences Inc. |
Rice, William Glenn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-420,373 vol |
14,489 | |
| Filed 2025-04-09 15:36 Tx date 2025-02-18 |
$APS
Aptose Biosciences Inc. |
Rice, William Glenn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-129,743 vol |
4,473 | |
| Filed 2025-04-09 15:34 Tx date 2025-02-18 |
$APS
Aptose Biosciences Inc. |
Platzer, Erich
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-36,087 vol |
1,242 | |
| Filed 2025-04-09 15:33 Tx date 2025-02-18 |
$APS
Aptose Biosciences Inc. |
Platzer, Erich
4 - Director of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-32,544 vol |
1,122 | |
| Filed 2025-04-09 15:31 Tx date 2025-02-18 |
$APS
Aptose Biosciences Inc. |
Payne, Charles Fletcher
5 - Senior Officer of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-130,500 vol |
4,499 | |
| Filed 2025-04-09 15:30 Tx date 2025-02-18 |
$APS
Aptose Biosciences Inc. |
Payne, Charles Fletcher
5 - Senior Officer of Issuer
Holder: Fletcher Payne 2019 Trust (Indirect Ownership)
|
Common Shares
37 - Stock split or consolidation
|
-644 vol |
22 | |
| Filed 2025-04-09 15:28 Tx date 2025-02-18 |
$APS
Aptose Biosciences Inc. |
Payne, Charles Fletcher
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-6,444 vol |
222 | |
| Filed 2025-04-09 15:27 Tx date 2025-02-18 |
$APS
Aptose Biosciences Inc. |
Burger, Denis
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-37,719 vol |
1,298 | |
| Filed 2025-04-09 15:26 Tx date 2025-02-18 |
$APS
Aptose Biosciences Inc. |
Burger, Denis
4 - Director of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-1,396 vol |
48 | |
| Filed 2025-04-09 15:24 Tx date 2025-02-18 |
$APS
Aptose Biosciences Inc. |
Bejar, Rafael
5 - Senior Officer of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-171,939 vol |
5,925 | |
| Filed 2025-04-09 15:23 Tx date 2025-02-18 |
$APS
Aptose Biosciences Inc. |
Bejar, Rafael
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-7,089 vol |
244 | |
| Filed 2025-04-09 15:20 Tx date 2025-02-18 |
$APS
Aptose Biosciences Inc. |
Ashe, Carol Gail
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-27,710 vol |
953 | |
| Filed 2025-03-20 17:04 Tx date 2025-03-19 |
$APS
Aptose Biosciences Inc. |
Hanmi Pharmaceutical Co., Ltd.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
$1,513,533
+409,063 vol $3.70 each |
508,710 |